Abstract

Aerococci have certain cultivation characteristics. A well-known method of aerococcal cultivation uses indicator media which included the complex "oxolinic acid – etonium", but data indicating cases of conditionally pathogenic flora contamination due to the accumulation of microorganisms that are resistant to this complex have been obtained. Therefore, there was a need to search for new substances that would have a wide range of antagonistic activity in relation to the conditionally pathogenic flora and at the same time would not inhibit the growth of aerococci, and which would also be available and safe. The sensitivity of the A. viridans symbionts and conditionally pathogenic flora to the substances with antimicrobial activity of different groups was determined by the method of "wells". For research, A. viridans symbionts isolated from different microbiocenoses have been used. P. aeruginosa, S. aureus, K. pneumoniae, E. coli and C. albicans were used as conditionally pathogenic flora. Norfloxacin, pefloxacin, ofloxacin, gatifloxacin, levofloxacin, miramistin, decamethoxine, chlorhexidine, octenidine and boric acid were used as investigational drugs. Also, the optimal concentration of drugs which would suppress the growth of conditionally pathogenic flora, and would not show a negative effect on A. viridans was determined by serial dilutions. It was found that miramistin, norfloxacin and boric acid meet the necessary criteria. The serum dilutions method was used to determine the minimum inhibitory concentration (MIC) of these drugs in the experiment. Norfloxacin in a dosage of 12.5–50.0 μg/ml effectively inhibited the growth of the conditionally pathogenic flora, but also reduced the number of aerococci. The dose of 8.3 μg/ml met the criteria we needed, namely suppressing the growth of the conditionally pathogenic flora and not affecting aerococci. The concentration of miramistin and boric acid in a culture medium that showed a stong depressant effect on conditionally pathogenic flora and practically did not affect A. viridans was 50 μg/ml. In addition, miramistin and boric acid exhibited fungicidal action against C. albicans. Antimicrobial effects of the investigated drugs on the conditionally pathogenic flora was not complete in some cases, or inhibited the growth of aerococci at higher doses, so the effect of their rational combination on the conditionally pathogenic flora was investigated. As a result, an antimicrobial complex with optimal concentrations of substances (norfloxacin 8.3 μg/ml, myramistin 50 μg/ml, boric acid 50 μg/ml), which effectively suppresses UPMF and does not affect the growth of symbionic A. viridans, was determined. The specified antimicrobial complex can be used for the production of modified media for isolation, cultivation and study of biochemical activity of A. viridans microorganisms. Properties of aerococci, grown on the nutrient medium with the studied drugs did not differ from aerococci, grown on nutrient media without additives.

Highlights

  • The above-mentioned facts and increased incidence of infections caused by hospital strains with multi-resistance to chemotherapy (Uh et al, 2002; Yasukawa et al, 2014; Gonzalez et al, 2017), especially methicillin-resistant Staphylococcus aureus (MRSA) (Cho & Chung, 2017), have created a need to search for new substances that would have a wide range of antagonistic activity in turn on the conditionally pathogenic flora (CPF) and inhibit the growth of aerococci at the same time and which should be accessible and safe

  • The experimental method (Stepanskyi & Kremenchutskyi, 2014) made it possible to discover the sensitivity of the A. viridans symbionts to fluoroquinolones and determined that norfloxacin at a dosage of 8.3 μg/ml practically did not affect the growth of aerococci and effectively suppresses the CPF

  • The minimum inhibitory concentrations (MICs) of drugs that suppressed the CPF growth and did not show a negative effect on A. viridans were determined by serial dilutions

Read more

Summary

Introduction

The optimal concentration of drugs which would suppress the growth of conditionally pathogenic flora, and would not show a negative effect on A. viridans was determined by serial dilutions. An antimicrobial complex with optimal concentrations of substances (norfloxacin 8.3 μg/ml, myramistin 50 μg/ml, boric acid 50 μg/ml), which effectively suppresses UPMF and does not affect the growth of symbionic A. viridans, was determined. In the process of use of these media, data indicating cases of conditionally pathogenic flora (CPF) contamination due to the accumulation of microorganisms that are resistant to the "oxolinic acid – etonium complex" were obtained. The experimental method (Stepanskyi & Kremenchutskyi, 2014) made it possible to discover the sensitivity of the A. viridans symbionts to fluoroquinolones and determined that norfloxacin at a dosage of 8.3 μg/ml practically did not affect the growth of aerococci and effectively suppresses the CPF. The purpose of the study was to select a selective antibacterial complex that would suppress the growth of UPMF and would not affect the growth of A. viridans, with the possibility of using it for the production of modified media for isolation, cultivation and study of the biochemical activity of A. viridans microorganisms

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.